12981_2020_272_MOESM1_ESM.docx (14.75 kB)
Additional file 1 of Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
journal contribution
posted on 2020-05-22, 03:31 authored by Sharlene Ho, Joshua Guoxian Wong, Oon Tek Ng, Cheng Chuan Lee, Yee Sin Leo, David Chien Boon Lye, Chen Seong WongAdditional file 1: Table S1. Baseline characteristics of patients in the RPV, EFV and boosted PI groups.